Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon in Congenital Hyperinsulinism at the 60th Annual ESPE Meeting

https://www.globenewswire.com/news-release/2022/09/19/2517958/0/en/Zealand-Pharma-Presents-Data-from-Phase-3-Trial-of-Dasiglucagon-in-Congenital-Hyperinsulinism-at-the-60th-Annual-ESPE-Meeting.html

press release